Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-31RA Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 3 publications
Supplier: R&D Systems AF2769
This item is not returnable.
View return policy
Description
IL-31RA Polyclonal specifically detects IL-31RA in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF-ready.Specifications
| IL-31RA | |
| Polyclonal | |
| Unconjugated | |
| Q8NI17 | |
| IL31RA | |
| Mouse myeloma cell line NS0-derived recombinant human IL-31 RA Ala20-Ser516 Accession # Q8NI17 | |
| 100 μg | |
| Primary | |
| Detects human IL-31 RA in direct ELISAs and Western blots. In direct ELISAs, approximately 5% cross-reactivity with recombinant mouse IL-31 RA is observed. | |
| Human | |
| IgG |
| Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF | |
| LYOPH | |
| Western Blot 0.1 ug/mL, Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 5-15 ug/mL, CyTOF-ready | |
| class I cytokine receptor, CRL3, CRL3Glmr, Cytokine receptor-like 3, GLMR, GLM-R, GLM-RMGC125346, GP130 like receptor, Gp130-like monocyte receptor, Gp130-like receptor, hGLM-R, IL-31 RA, IL-31 receptor subunit alpha, IL-31R subunit alpha, IL31RA, IL-31RAGPLCRL, IL-31R-alpha, interleukin 31 receptor A, interleukin-31 receptor subunit alpha, PRO21384, soluble type I cytokine receptor CRL3, ZcytoR17 | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 133396 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction